Standard Research

Enjoy our market updates, in-house videos, media interviews, data analysis and more.

Please visit our Premium Research section for daily actionable analysis, including updated fundamentals, technicals, actionable bias, and proprietary tradable levels.

Blue Line Futures Research

How Will Stocks Respond To The Federal Reserve? | TD Ameritrade Interview 4.21.22

Posted: April 21, 2022, 1:39 p.m.

Bill Baruch, President of Blue Line Capital Joins TD Ameritrade Network 4/21/22.

Key Takeaways:

-Crude Oil's Rally is still in the early innings, just getting started.

-$TSLA earnings has aided equity markets on the heels of $NFLX debacle of a quarter this morning.

-Fed Speak from St Louis Fed President James Bullard put a 75 bps raise on the table for May's meeting. If Powell is seen by the market agreeing, equities are going to lean on the bearish side.

-Hawkish comments are also emerging from the ECB. -2.98% was the high for the 10yr US Bond Note yesterday.

-Bill Baruch believes that if the Fed rips the band aid off (raising rates quickly), we could see some of the commodities come in, and inflationary pressures relaxed.

Sign up for a 14-day, no-obligation free trial of our proprietary research with actionable ideas!
Free Trial Subscribe to our YouTube Channel
Email [email protected] or call 312-278-0500 with any questions -- our trade desk is here to help with anything on the board!

Futures trading involves a substantial risk of loss and may not be suitable for all investors. Trading advice is based on information taken from trade and statistical services and other sources Blue Line Futures, LLC believes are reliable. We do not guarantee that such information is accurate or complete and it should not be relied upon as such. Trading advice reflects our good faith judgment at a specific time and is subject to change without notice. There is no guarantee that the advice we give will result in profitable trades. All trading decisions will be made by the account holder. Past performance is not necessarily indicative of future results.

Like this post? Share it below:

Back to Insights